Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Interventional Pulmonology

Safety of Diagnostic Bronchoscopy in Patients with Pulmonary Hypertension

Diaz-Guzman E.a · Vadi S.b · Minai O.A.a · Gildea T.R.a · Mehta A.C.a

Author affiliations

aRespiratory Institute, Cleveland Clinic, Cleveland, Ohio, and bDepartment of Internal Medicine, Maryland General Hospital, Baltimore, Md., USA

Related Articles for ""

Respiration 2009;77:292–297

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Interventional Pulmonology

Received: July 05, 2008
Accepted: October 17, 2008
Published online: January 28, 2009
Issue release date: April 2009

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 4

ISSN: 0025-7931 (Print)
eISSN: 1423-0356 (Online)

For additional information: https://www.karger.com/RES

Abstract

Background: Patients with pulmonary hypertension (PH) are considered to be at risk for complications associated with flexible bronchoscopy (FB). Although previous reports suggest that transbronchial biopsies increase the risk for hemorrhage in this population, data are limited to survey analyses and isolated reports. Objectives: It was the aim of this study to describe our experience with FB and to determine if bronchoscopic procedures are associated with adverse events in this population. Methods: We conducted a retrospective review of patients with diagnosis of PH who underwent FB at the Cleveland Clinic between 2002 and 2005. Patients without PH who underwent FB by the same pulmonary physician were used as controls. Results: A total of 90 patients, PH (n = 45) versus controls (n = 45), were included. The mean systolic pulmonary artery pressure in patients with PH was 58 ± 7 mm Hg. Patients with PH had higher oxygen requirements at baseline (FiO2 0.42 vs. 0.3%; p = 0.01). The total number of procedures was similar between the groups (95 vs. 102). Procedures performed were bronchoalveolar lavage (21 vs. 13), transbronchial biopsies (24 vs. 32) and transbronchial needle aspiration (7 vs. 6). There were no hemodynamic complications or episodes of respiratory failure associated with the procedures. None of the patients had significant hemorrhage and only 2 developed mild bleeding which resolved spontaneously. Similarly, none required hospitalization or transfer to an intensive care unit. Conclusions: FB can be performed safely in patients with mild to moderate PH. Transbronchial biopsies are not associated with worsening hypoxemia or an increased risk of hemorrhage. Prospective studies with hemodynamic measurements are necessary to confirm these findings.

© 2009 S. Karger AG, Basel


References

  1. Colt HG, Prakash UBS, Offord KP: Bronchoscopy in North America: survey by the American Association for Bronchology, 1999. J Bronchol 2000;7:8–25.
    External Resources
  2. Ernst A, Silvestri GA, Johnstone D: Interventional pulmonary procedures: guidelines from the American College of Chest Physicians. Chest 2003;123:1693–1717.
  3. Pue CA, Pacht ER: Complications of fiberoptic bronchoscopy at a university hospital. Chest 1995;107:430–432.
  4. Pereira W Jr, Kovnat DM, Snider GL: A prospective cooperative study of complications following flexible fiberoptic bronchoscopy. Chest 1978;73:813–816.
  5. Guidelines for fiberoptic bronchoscopy in adults. American Thoracic Society. Medical section of the American Lung Association. Am Rev Respir Dis 1987;136:1066.
    External Resources
  6. Ramakrishna G, Sprung J, Ravi BS, Chandrasekaran K, McGoon MD: Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol 2005;45:1691–1699.
  7. Carmosino MJ, Friesen RH, Doran A, Ivy DD: Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization. Anesth Analg 2007;104:521–527.
  8. Lai HC, Wang KY, Lee WL, Ting CT, Liu TJ: Severe pulmonary hypertension complicates postoperative outcome of non-cardiac surgery. Br J Anaesth 2007;99:184–190.
  9. Lundgren R, Haggmark S, Reiz S: Hemodynamic effects of flexible fiberoptic bronchoscopy performed under topical anesthesia. Chest 1982;82:295–299.
  10. Bein T, Pfeifer M, Keyl C, Metz C, Taeger K: Right ventricular function and plasma atrial natriuretic peptide levels during fiberbronchoscopic alveolar lavage in critically ill, mechanically ventilated patients. Chest 1995;108:1030–1035.
  11. Wahidi MM, Rocha AT, Hollingsworth JW, Govert JA, Feller-Kopman D, Ernst A: Contraindications and safety of transbronchial lung biopsy via flexible bronchoscopy. A survey of pulmonologists and review of the literature. Respiration 2005;72:285–295.
  12. Gorman SR, Beamis JF: Complications of flexible bronchoscopy. Clin Pulmonary Med 2005;12:177.
    External Resources
  13. Jin F, Mu D, Chu D, Fu E, Xie Y, Liu T: Severe complications of bronchoscopy. Respiration 2008;76:429–433.
  14. Dweik RA, Mehta AC, Meeker DP, Arroliga AC: Analysis of the safety of bronchoscopy after recent acute myocardial infarction. Chest 1996;110:825–828.
  15. Ohmichi M, Tagaki S, Nomura N, Tsunematsu K, Suzuki A: Endobronchial changes in chronic pulmonary venous hypertension. Chest 1988;94:1127–1132.
  16. AARC clinical practice guideline. Bronchoscopy assisting – 2007 revision and update. Respir Care 2007;52:74–80.
    External Resources
  17. British Thoracic Society guidelines on diagnostic flexible bronchoscopy. Thorax 2001;56(suppl 1):i1–i21.
  18. Rich S, McLaughlin VV, O’Neill W: Stenting to reverse left ventricular ischemia due to left main coronary artery compression in primary pulmonary hypertension. Chest 2001;120:1412–1415.
  19. Runo JR, Loyd JE: Primary pulmonary hypertension. Lancet 2003;361:1533–1544.
  20. Credle WF Jr, Smiddy JF, Elliott RC: Complications of fiberoptic bronchoscopy. Am Rev Respir Dis 1974;109:67–72.
    External Resources
  21. Milman N, Faurschou P, Grode G, Jorgensen A: Pulse oximetry during fibreoptic bronchoscopy in local anaesthesia: frequency of hypoxaemia and effect of oxygen supplementation. Respiration 1994;61:342–347.
  22. Barst RJ: Medical therapy of pulmonary hypertension. An overview of treatment and goals. Clin Chest Med 2001;22:509–515, ix.
  23. Chhajed PN, Wallner J, Stolz D, Baty F, Strobel W, Brutsche MH, Tamm M: Sedative drug requirements during flexible bronchoscopy. Respiration 2005;72:617–621.
  24. Prakash UB, Offord KP, Stubbs SE: Bronchoscopy in North America: the ACCP survey. Chest 1991;100:1668–1675.
  25. Ouellette DR: The safety of bronchoscopy in a pulmonary fellowship program. Chest 2006;130:1185–1190.
  26. Zavala DC: Pulmonary hemorrhage in fiberoptic transbronchial biopsy. Chest 1976;70:584–588.
  27. Schulman LL, Smith CR, Drusin R, Rose EA, Enson Y, Reemtsma K: Utility of airway endoscopy in the diagnosis of respiratory complications of cardiac transplantation. Chest 1988;93:960–967.
  28. Morris MJ, Peacock MD, Lloyd WC, Blanton HM: The effect of pulmonary hypertension upon bleeding in sheep undergoing bronchoscopic biopsy. J Bronchol 1996;3:11–16.
    External Resources
  29. Morris MJ, Peacock MD, Mego DM, Johnson JE, Anders GT: The risk for hemorrhage from bronchoscopic lung biopsy due to pulmonary hypertension in interstitial lung disease. J Bronchol 1998;5:117–121.
    External Resources
  30. Herf SM, Suratt PM, Arora NS: Deaths and complications associated with transbronchial lung biopsy. Am Rev Respir Dis 1977;115:708–711.
  31. Suratt PM, Smiddy JF, Gruber B: Deaths and complications associated with fiberoptic bronchoscopy. Chest 1976;69:747–751.

Article / Publication Details

First-Page Preview
Abstract of Interventional Pulmonology

Received: July 05, 2008
Accepted: October 17, 2008
Published online: January 28, 2009
Issue release date: April 2009

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 4

ISSN: 0025-7931 (Print)
eISSN: 1423-0356 (Online)

For additional information: https://www.karger.com/RES


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.